- 1701. Nodular lymphoma involving lymph nodes of multiple sites
- (UMLS (ICD9CM) C0153801) =Neoplastic Process
| - 1751. Non-covered service submitted for FI review (condition code 20 from header information on claim)
- (UMLS (HL7) C1547453) =Intellectual Product =OCE Edit Code;
|
- 1702. Nodular lymphoma involving spleen
- (UMLS (ICD9CM) C0153800) =Neoplastic Process
| - 1752. Non-covered service submitted for verification of denial (condition code 21 from header information on claim)
- (UMLS (HL7) C1547452) =Intellectual Product =OCE Edit Code;
|
- 1703. Nodular Malignant Melanoma
- [An aggressive form of melanoma, frequently metastasizing to the lymph nodes. It presents as a papular or nodular raised skin lesion. It comprises approximately 10-15% of melanomas. Morphologically, it often displays an epithelioid appearance. ( NCI )] (UMLS (NCI) C0334424) =Neoplastic Process
| - 1753. Non-emergency Medical Transport (VAN)
- [A land vehicle with a capacity to meet special height, clearance, access, and seating, for the conveyance of persons in non-emergency situations. The vehicle may or may not be required to meet local county or state regulations. ( HL7V3.0 )] (UMLS (HL7) C1552510) =Intellectual Product ;
=Transportation Services;
|
- 1704. Nodular Neoplasm
- (UMLS (NCI) C1334971) Nodular Tumor =Neoplastic Process
| - 1754. Non-Emergent Practitioner (i.e. medical ethics committee)
- (UMLS (HL7) C1549089) =Idea or Concept =Signatory_s Relationship to Subject;
|
- 1705. Nodular Pattern
- (UMLS (NCI) C1334972) =Finding
| - 1755. Non-Encapsulated Neoplasm
- (UMLS (NCI) C1334975) =Neoplastic Process
|
- 1706. Nodular prostate
- (UMLS (ICD9CM) C0748012) =Disease or Syndrome
| - 1756. Non-English speaking
- (UMLS (HL7) C1546417) =Finding =Ambulatory Status;
|
- 1707. Nodular Sclerosis Hodgkin's Disease Stage I
- [Ann Arbor Classification: Stage I: Involvement of a single lymph node region (I); or localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement (IE) (rare in Hodgkin lymphoma).- 2003 ( NCI )] (UMLS (NCI) C0855087) Nodular Sclerosis Hodgkin's Lymphoma Stage I;
Stage I Nodular Sclerosis Hodgkin Lymphoma;
Stage I Nodular Sclerosis Hodgkin's Disease;
Stage I Nodular Sclerosis Hodgkin's Lymphoma;
=Neoplastic Process | - 1757. Non-Essential Amino Acid
- [Refers to those amino acids that your body can create out of other chemicals found in your body. ( NCI )] (UMLS (NCI) C0311461) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance
|
- 1708. Nodular Sclerosis Hodgkin's Disease Stage II
- [Ann Arbor Classification: Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm (II); or localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph node regions on the same side of the diaphragm (IIE). - 2003 ( NCI )] (UMLS (NCI) C1336303) Nodular Sclerosis Hodgkin's Lymphoma Stage II;
Stage II Nodular Sclerosis Hodgkin Lymphoma;
Stage II Nodular Sclerosis Hodgkin's Disease;
Stage II Nodular Sclerosis Hodgkin's Lymphoma;
=Neoplastic Process | - 1758. Non-familiar Idiopathic Dystonia
- (UMLS (NCI) C0393601) =Disease or Syndrome
|
- 1709. Nodular Sclerosis Hodgkin's Disease Stage IV
- [Ann Arbor Classification: Stage IV: Diffuse or disseminated involvement of one or more extralymphatic organs, with or without associated lymph node involvement; or isolated extralymphatic organ involvement in the absence of adjacent regional lymph node involvement, but in conjunction with disease in distant site(s); or any involvement of the liver or bone marrow or nodular involvement of the lung(s). - 2003 ( NCI )] (UMLS (NCI) C0855088) Nodular Sclerosis Hodgkin's Lymphoma Stage IV;
Stage IV Nodular Sclerosis Hodgkin Lymphoma;
Stage IV Nodular Sclerosis Hodgkin's Disease;
Stage IV Nodular Sclerosis Hodgkin's Lymphoma;
=Neoplastic Process | - 1759. Non-Functioning Pancreatic Delta Cell Neoplasm
- [A usually malignant endocrine neoplasm arising from the delta cells of the pancreas. It is not associated with a hormonal syndrome. — 2005 ( NCI )] (UMLS (NCI) C1335311) Non-Functioning Pancreatic Delta Cell Tumor;
=Neoplastic Process |
- 1710. nodule
- [(NOD-yool) A growth or lump that may be cancerous or noncancerous. ( NCI )] (UMLS (NCI) C0028259) =Acquired Abnormality ;
| - 1760. Non-Graduate
- (UMLS (HL7) C1549985) =Intellectual Product =Degree/license/certificate;
|
- 1711. Nodule of the Thyroid
- [A small circumscribed mass in the THYROID GLAND that can be of neoplastic growth or non-neoplastic abnormality. It lacks a well-defined capsule or glandular architecture. Thyroid nodules are often benign but can be malignant. The growth of nodules can lead to a multinodular goiter (GOITER, NODULAR). ( MSH )] (UMLS (NCI) C0040137) =Neoplastic Process =Neoplasm of the Thyroid;
| - 1761. NON-HEALING SURGCL WOUND
- [ ] (UMLS (ICD9CM) C0375732) =Pathologic Function
|
- 1712. Nodule of the Vocal Cord
- (UMLS (NCI) C0396053) =Finding
| - 1762. Non-healthcare professional
- (UMLS (HL7) C1546929) =Idea or Concept =Report source;
|
- 1713. Nodule(s)
- (UMLS (HL7) C1546722) =Intellectual Product =Specimen Source Codes;
| - 1763. Non-Hemolytic Fever Chill Transfusion Reaction _ First
- (UMLS (HL7) C1549014) =Pathologic Function =Transfusion Adverse Reaction;
|
- 1714. Nodule, Cystic
- (UMLS (HL7) C1546593) =Intellectual Product =Specimen Source Codes;
| - 1764. Non-Hemolytic Fever Chill Transfusion Reaction _ Recurrent
- (UMLS (HL7) C1549015) =Pathologic Function =Transfusion Adverse Reaction;
|
- 1715. Nodulo-Ulcerative Basal Cell Carcinoma
- (UMLS (NCI) C0862887) Skin Nodulo-Ulcerative Basal Cell Carcinoma =Neoplastic Process
| - 1765. Non-Hemolytic Fever Chill Transfusion Reaction _ Repeating
- (UMLS (HL7) C1549016) =Pathologic Function =Transfusion Adverse Reaction;
|
- 1716. NOE (nuclear Overhauser enhancement)
- [ ] (UMLS (CSP) C0598986) =Diagnostic Procedure ;
| - 1766. Non-hemolytic Hypotensive Reaction
- (UMLS (HL7) C1549013) =Pathologic Function =Transfusion Adverse Reaction;
|
- 1717. NOESY
- [ ] (UMLS (CSP) C0599864) =Diagnostic Procedure ;
| - 1767. Non-Hereditary Clear Cell Renal Cell Carcinoma
- [The most common type of renal cell carcinoma, characterized by a loss of genetic material of the short arm of chromosome 3. The most common symptom at the time of diagnosis is hematuria. The tumor has a golden-yellow color because of the abundance of intracytoplasmic lipid. This is a clinically aggressive type of renal cell carcinoma. The tumor usually metastasizes to unusual sites and late metastasis is common. ( NCI )] (UMLS (NCI) C1334978) Non-Hereditary Conventional (Clear Cell) Renal Cell Carcinoma;
Sporadic Clear Cell Renal Cell Carcinoma;
Sporadic Conventional (Clear Cell) Renal Cell Carcinoma =Neoplastic Process |
- 1718. NoInformation
- [No information whatsoever can be inferred from this exceptional value. This is the most general exceptional value. It is also the default exceptional value. ( HL7V3.0 )] (UMLS (HL7) C1550693) =Idea or Concept =NullFlavor;
=not applicable;
masked;
other;
unknown;
| - 1768. Non-Hodgkin Breast Lymphoma
- (UMLS (NCI) C1335489) Non-Hodgkin's Breast Lymphoma;
Primary Non-Hodgkin Breast Lymphoma;
Primary Non-Hodgkin Lymphoma of Breast;
Primary Non-Hodgkin Lymphoma of the Breast;
Primary Non-Hodgkin's Breast Lymphoma;
Primary Non-Hodgkin's Lymphoma of Breast;
Primary Non-Hodgkin's Lymphoma of the Breast =Neoplastic Process ;
|
- 1719. noise
- [undesired sound, especially a random mix of different frequencies. ( CSP )] (UMLS (CSP) C0028263) =Phenomenon or Process ;
=sound;
=noise pollution;
| - 1769. Non-Hodgkin Lymphoma by Clinical Course
- (UMLS (NCI) C1334979) Non-Hodgkin's Lymphoma by Clinical Course =Neoplastic Process
|
- 1720. noise biological effect
- [ ] (UMLS (CSP) C0597073) =Biomedical Occupation or Discipline ;
=Biophysical;
| - 1770. Non-Hodgkin Lymphoma of Spleen
- (UMLS (NCI) C1336071) Non-Hodgkin Lymphoma of the Spleen;
Non-Hodgkin's Lymphoma of Spleen;
Non-Hodgkin's Lymphoma of the Spleen;
Primary Splenic Non-Hodgkin's Lymphoma;
Splenic Non-Hodgkin Lymphoma;
Splenic Non-Hodgkin's Lymphoma =Neoplastic Process |
- 1721. NOISE EFFECT-EAR/NOS
- [ ] (UMLS (ICD9CM) C0155531) =Injury or Poisoning
| - 1771. Non-Hodgkin Lymphoma with Variable Clinical Course
- (UMLS (NCI) C1334980) Non-Hodgkin's Lymphoma with Variable Clinical Course =Neoplastic Process
|
- 1722. noise induced deafness
- [hearing loss due to exposure to explosive loud noise or chronic exposure to sound level greater than 85 dB. The hearing loss is often in the frequency range 4000-6000 hertz. ( CSP )] (UMLS (CSP) C0597074) =Injury or Poisoning ;
=deafness;
| - 1772. Non-Hodgkin's Lymphoma of Parotid
- (UMLS (NCI) C1335365) Non-Hodgkin's Lymphoma of Parotid Gland;
Non-Hodgkin's Lymphoma of the Parotid;
Non-Hodgkin's Lymphoma of the Parotid Gland;
Parotid Gland Non-Hodgkin Lymphoma;
Parotid Gland Non-Hodgkin's Lymphoma;
Parotid Non-Hodgkin's Lymphoma;
Primary Parotid Gland Non-Hodgkin's Lymphoma =Neoplastic Process ;
|
- 1723. noise perception
- [ ] (UMLS (CSP) C0599667) =Mental Process
| - 1773. Non-Hodgkin's Lymphoma of Prostate
- (UMLS (NCI) C1335516) Non-Hodgkin's Lymphoma of the Prostate;
Primary Prostate Non-Hodgkin's Lymphoma;
Prostate Non-Hodgkin Lymphoma;
Prostate Non-Hodgkin's Lymphoma =Neoplastic Process ;
|
- 1724. noise pollution
- [unwanted or harmful sounds in the environment. ( CSP )] (UMLS (CSP) C0686918) =Environmental Effect of Humans ;
=noise;
| - 1774. Non-Hodgkin's Lymphoma of the Thyroid
- [A non-Hodgkin lymphoma primarily involving the thyroid gland. The vast majority of cases are either mucosa-associated lymphoid tissue lymphomas or diffuse large B-cell lymphomas. (NCI05) ( NCI )] (UMLS (NCI) C1336755) Non-Hodgkin's Lymphoma of the Thyroid Gland;
Non-Hodgkin's Lymphoma of Thyroid;
Non-Hodgkin's Lymphoma of Thyroid Gland;
Primary Thyroid Gland Non-Hodgkin's Lymphoma;
Thyroid Gland Non-Hodgkin Lymphoma;
Thyroid Gland Non-Hodgkin's Lymphoma;
Thyroid Non-Hodgkin Lymphoma;
Thyroid Non-Hodgkin's Lymphoma =Neoplastic Process ;
|
- 1725. nolatrexed
- [An anticancer drug that belongs to the family of drugs called thymidylate synthase inhibitors. Also called AG337. ( NCI )] (UMLS (NCI) C0796399) =Organic Chemical; Pharmacologic Substance ;
| - 1775. Non-Hodgkin's Lymphoma Relapsed
- (UMLS (NCI) C0854866) Recurrent Non-Hodgkin Lymphoma;
Recurrent Non-Hodgkin's Lymphoma;
Relapsed Non-Hodgkin's Lymphoma;
=Neoplastic Process |
- 1726. nolvadex
- [ ] (UMLS (CSP) C0919390) =Organic Chemical; Pharmacologic Substance ;
| - 1776. Non-Hodgkin's Lymphoma Stage I
- [Cancer found in only one lymph node area or one area or organ outside the lymph nodes. ( NCI )] (UMLS (NCI) C0677955) =Neoplastic Process
|
- 1727. Nomadic
- [Nomadic ( HL7V3.0 )] (UMLS (HL7) C1550451) =Idea or Concept =LivingArrangement;
| - 1777. Non-Hodgkin's Lymphoma Stage II
- [Cancer that is found in two or more lymph node areas on the same side of the diaphragm (the muscle under the lungs that helps breathing). Cancer is found in only one area or organ outside the lymph nodes and in the lymph nodes around it. Other lymph node areas on the same side of the diaphragm may also have cancer. ( NCI )] (UMLS (NCI) C0677956) =Neoplastic Process
|
- 1728. Nome Eskimo Community
- (UMLS (HL7) C1550939) =Population Group =NativeEntityAlaska;
| - 1778. Non-Hodgkin's Lymphoma Stage III
- [Cancer is found in lymph node areas on both sides of the diaphragm. The cancer may also have spread to an area or organ near the lymph node areas, to the spleen, or both. ( NCI )] (UMLS (NCI) C0677957) =Neoplastic Process
|
- 1729. nomenclature
- [system of words used in a particular discipline; examples include legal terminology, chemical terminology, medical terminology, etc. ( CSP )] (UMLS (CSP) C0600281) =Intellectual Product =vocabulary;
=vocabulary development for information system | - 1779. Non-Hodgkin's Lymphoma Stage IV
- [Cancer has spread to more than one organ or organs outside the lymph system. Cancer cells may be found in the lymph nodes near these organs. Cancer has spread to only one organ outside the lymph system, but lymph nodes far away from that organ are involved. ( NCI )] (UMLS (NCI) C0677958) =Neoplastic Process
|
- 1730. Non Parametric Probability Distribution
- (UMLS (HL7) C1552661) =Quantitative Concept =Type;
◊ (UMLS (HL7) C1552698) Quantitative Concept Set Of Uncertain Value Probabilistic; | - 1780. Non-Human Gene
- [Genes from any non-human organism. ( NCI )] (UMLS (NCI) C1334981) =Gene or Genome
|
- 1731. Non Parametric Probability Distribution Of Concept Descriptors
- (UMLS (HL7) C1552730) =Quantitative Concept =Set Of Uncertain Probabilistic Concept Descriptor;
| - 1781. Non-Human Protein
- [Proteins from organisms other than human. ( NCI )] (UMLS (NCI) C1334982) =Amino Acid, Peptide, or Protein
|
- 1732. Non Parametric Probability Distribution Of Intervals of Physical Quantities
- (UMLS (HL7) C1552731) =Quantitative Concept =Set Of Uncertain Probabilistic Interval Of Physical Quantities;
| - 1782. Non-Immune Hemolysis
- (UMLS (HL7) C1549017) =Pathologic Function =Transfusion Adverse Reaction;
|
- 1733. Non Small Cell Lung Cancer Recurrent
- [The re-emergence of non-small cell lung cancer after a period of remission. (NCI05) ( NCI )] (UMLS (NCI) C0278517) =Neoplastic Process
| - 1783. Non-Invasive Bladder Urothelial Carcinoma
- (UMLS (NCI) C1336089) Stage 0 Bladder Urothelial Carcinoma;
Stage 0 Transitional Cell Carcinoma of Bladder;
Stage 0 Transitional Cell Carcinoma of the Bladder;
Stage 0 Transitional Cell Carcinoma of the Urinary Bladder;
Stage 0 Transitional Cell Carcinoma of Urinary Bladder;
Stage 0 Urinary Bladder Transitional Cell Carcinoma =Neoplastic Process |
- 1734. Non Small Cell Lung Cancer Stage II
- [Cancer that has spread to nearby lymph nodes. ( NCI )] (UMLS (NCI) C0278505) =Neoplastic Process
| - 1784. NON-INVASIVE BONE STIMUL
- [ ] (UMLS (ICD9CM) C0178230) =Therapeutic or Preventive Procedure
|
- 1735. Non Small Cell Lung Cancer Stage IIIA
- [Stage 3a includes T1 or T2,N2,MO/T3,N1 or N2,MO. N2: Metastasis to ipsilateral mediastinal and/or subcarinal lymph node(s). ( NCI )] (UMLS (NCI) C0278983) =Neoplastic Process
| - 1785. Non-Invasive Lesion
- (UMLS (NCI) C1334983) =Finding
|
- 1736. Non Small Cell Lung Cancer Stage IIIB
- [Stage 3b includes anyT,N3,MO/T4,anyN,MO. T4: A tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, esophagus, vertebral body, carina; or separate tumor nodules in the same lobe; or tumor with a malignant pleural effusion. N3: Metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s). ( NCI )] (UMLS (NCI) C0278984) =Neoplastic Process
| - 1786. Non-Invasive Papillary Squamous Cell Carcinoma
- [A well differentiated squamous cell carcinoma characterized by a papillary, exophytic growth pattern, hyperkeratosis, and absence of invasion of adjacent tissues. ( NCI )] (UMLS (NCI) C1266003) =Neoplastic Process
|
- 1737. Non Specific Chronic Endometritis
- (UMLS (NCI) C1335061) =Disease or Syndrome ;
| - 1787. Non-Invasive Papillary Transitional Cell Carcinoma
- [A transitional cell carcinoma characterized by a papillary growth pattern and lack of stromal invasion. ( NCI )] (UMLS (NCI) C1266011) =Neoplastic Process
|
- 1738. Non-acute
- (UMLS (HL7) C1547228) =Intellectual Product =Triage Code;
| - 1788. Non-Invasive Penile Verrucous Carcinoma
- (UMLS (NCI) C1334984) Non-Invasive Verrucous Carcinoma of Penis;
Non-Invasive Verrucous Carcinoma of the Penis;
=Neoplastic Process |
- 1739. Non-acute inflammation
- (UMLS (HL7) C1547216) =Intellectual Product =Tissue Type Code;
| - 1789. Non-Keratinizing Large Cell Squamous Cell Carcinoma
- [A squamous cell carcinoma composed of large atypical cells, without morphologic evidence of keratin production. ( NCI )] (UMLS (NCI) C0334248) =Neoplastic Process
|
- 1740. Non-Allergy Intolerance
- [Hypersensitivity to an agent caused by a mechanism other than an immunologic response to an initial exposure ( HL7V3.0 )] (UMLS (HL7) C1697900) =Clinical Attribute =intolerance;
=Food Non-Allergy Intolerance;
Environmental Non-Allergy Intolerance;
Drug Non-Allergy Intolerance;
| - 1790. Non-Keratinizing Primary Intraosseous Squamous Cell Carcinoma Arising de novo
- (UMLS (NCI) C1334985) Non-Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type =Neoplastic Process
|
- 1741. Non-Burkitt's Lymphoma
- (UMLS (NCI) C1403404) =Neoplastic Process ;
| - 1791. Non-Keratinizing Sinonasal Squamous Cell Carcinoma
- [A squamous cell carcinoma of the sinonasal tract characterized by a plexiform or ribbon-like growth pattern, cytological atypia, and lack of histological evidence of keratinization. ( NCI )] (UMLS (NCI) C0334270) =Neoplastic Process
|
- 1742. Non-Concur Code/Description
- (UMLS (HL7) C1547639) =Idea or Concept =HL7 Vocabulary Version 2.5;
| - 1792. Non-Keratinizing Small Cell Squamous Cell Carcinoma
- [A squamous cell carcinoma composed of small atypical cells, without morphologic evidence of keratin production. ( NCI )] (UMLS (NCI) C0334249) =Neoplastic Process
|
- 1743. Non-Contiguous Adult Diffuse Mixed Cell Lymphoma Stage II
- (UMLS (NCI) C0677707) =Neoplastic Process ;
| - 1793. Non-Malignant Cellular Infiltrate
- (UMLS (NCI) C1334987) =Finding
|
- 1744. Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma Stage II
- (UMLS (NCI) C0677704) =Neoplastic Process
| - 1794. Non-malignant neoplasm
- (UMLS (HL7) C1547217) =Intellectual Product =Tissue Type Code;
|
- 1745. Non-Contiguous Adult Diffuse Small Non-Cleaved Cell Lymphoma Stage II
- (UMLS (NCI) C0677710) =Neoplastic Process ;
| - 1795. Non-Measurable Lesion
- [A neoplasm for which no exact measurement may be obtained. This may be due to a size below detection, an invasive presentation, or pertain to an effusion or ascites. ( NCI )] (UMLS (NCI) C1334988) =Finding
|
- 1746. Non-Contiguous Follicular Large Cell Lymphoma Stage II
- (UMLS (NCI) C0677703) =Neoplastic Process
| - 1796. Non-Melanomatous Lesion
- (UMLS (NCI) C1334989) =Finding
|
- 1747. Non-Contiguous Follicular Mixed Cell Lymphoma Stage II
- (UMLS (NCI) C0677702) =Neoplastic Process
| - 1797. Non-Metastatic Fibrosarcoma
- [A usually aggressive primary malignant neoplasm arising from the soft tissues. It is characterized by the presence of spindle-shaped fibroblasts and collagenous stroma formation in a herringbone growth pattern. ( NCI )] (UMLS (NCI) C0855055) Primary Fibrosarcoma =Neoplastic Process
|
- 1748. Non-Contiguous Follicular Small Cleaved Cell Lymphoma Stage II
- (UMLS (NCI) C0677701) =Neoplastic Process
| - 1798. Non-Metastatic Gestational Trophoblastic Neoplasm
- (UMLS (NCI) C0280478) =Neoplastic Process ;
|
- 1749. Non-Contiguous Mantle Cell Lymphoma Stage II
- (UMLS (NCI) C0677705) =Neoplastic Process
| - 1799. Non-Metastatic Neoplasm
- (UMLS (NCI) C1334991) =Neoplastic Process
|
- 1750. Non-covered Insurance Code
- (UMLS (HL7) C1550417) =Intellectual Product =HL7 Vocabulary Version 2.5;
| - 1800. Non-Metastatic Synovial Sarcoma
- [Synovial sarcoma affecting an anatomic site as a primary tumor.--2004 ( NCI )] (UMLS (NCI) C0855071) Primary Synovial Sarcoma;
Synovial Sarcoma Nonmetastatic;
=Neoplastic Process |
home 
Armenian-English 
top